Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14639994 | 1.00 | PDE4A (0.41) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL13879019 | 0.85 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL15239580 | 0.85 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL8971728 | 0.85 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL27845927 | 0.85 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL14411835 | 0.85 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL8095380 | 0.83 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL343766 | 0.83 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL13998446 | 0.83 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL4160010 | 0.83 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119424690-A | Electronegativity-adjustable contrast agent film forming agent composition, contrast agent and preparation method thereof | 北京大学 | 2025-02-14 | — | — | CN | claimed |
| US-20260028406-A1 | NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-01-29 | — | — | US | disclosed |
| CN-119424690-A | Electronegativity-adjustable contrast agent film forming agent composition, contrast agent and preparation method thereof | 北京大学 | 2025-02-14 | — | — | CN | disclosed |
| US-20240327493-A1 | PD-1 AGONIST | GEORGE MASON UNIVERSITY | 2024-10-03 | — | — | US | disclosed |
| CN-103261430-A | Targeted perhydrolases | DU PONT | 2013-08-21 | — | — | CN | disclosed |
| CN-101558161-B | Production of peracids using enzymes having perhydrolysis activity | DU PONT | 2013-05-01 | — | — | CN | disclosed |
| CN-102906256-A | Process for purification of proteins | DU PONT | 2013-01-30 | — | — | CN | disclosed |
| WO-2012087790-A1 | PERHYDROLASE VARIANT PROVIDING IMPROVED SPECIFIC ACTIVITY | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2012-06-28 | — | — | WO | disclosed |
| CN-102264894-A | Enzyme catalyzed peracid generating formulation | — | 2011-11-30 | — | — | CN | disclosed |
| CN-101300333-B | Enzymatic production of peracids from carboxylic acid ester substrates using non-heme haloperoxidases | E. I. DU PONT DE NEMOURS AND CO. (US) | 2011-11-30 | — | — | CN | disclosed |
| CN-102177234-A | control of enzymatic peracid production | DU PONT | 2011-09-07 | — | — | CN | disclosed |
| CN-102168114-A | Enzymatic production of peracids from carboxylic acid ester substrates using non-heme haloperoxidases | DU PONT | 2011-08-31 | — | — | CN | disclosed |
| CN-101970674-A | Production of peracids using enzymes having perhydrolytic activity | DU PONT | 2011-02-09 | — | — | CN | disclosed |
| CN-101864155-A | Resin composition, molding thereof and process for producing the resin composition | SONY CORP | 2010-10-20 | — | — | CN | disclosed |
| CN-101558161-A | Production of peracids using enzymes having perhydrolysis activity | DU PONT (US) | 2009-10-14 | — | — | CN | disclosed |
| CN-101300333-A | Enzymatic production of peracids from carboxylic acid ester substrates using non-heme haloperoxidases | DU PONT (US) | 2008-11-05 | — | — | CN | disclosed |
| CN-101283100-A | Enzymatic production of peracids using lactobacilli having perhydrolysis activity | DU PONT (US) | 2008-10-08 | — | — | CN | disclosed |
| CN-1914266-A | Resin composition, shaped article using such resin composition and method for producing resin composition | SONY CORP (JP) | 2007-02-14 | — | — | CN | disclosed |
| CN-1914278-A | Resin composition, molded article thereof, and method for producing the resin composition | SONY CORP (JP) | 2007-02-14 | — | — | CN | disclosed |
| US-RE28729-E | Process for synthesizing specific complete mixed polyol esters | THE PROCTER & GAMBLE COMPANY (US) | 1976-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028406-A1 | NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT | VSIG8, VSIR, IGLV6-57 | PDE4A 1891/4885LMNA 1407/4885L3MBTL1 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.